Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
Abstract Aceruloplasminemia is a monogenic disease caused by mutations in the ceruloplasmin gene that result in loss of protein ferroxidase activity. Ceruloplasmin plays a role in iron homeostasis, and its activity impairment leads to iron accumulation in liver, pancreas, and brain. Iron deposition...
Main Authors: | Alan Zanardi, Antonio Conti, Marco Cremonesi, Patrizia D'Adamo, Enrica Gilberti, Pietro Apostoli, Carlo Vittorio Cannistraci, Alberto Piperno, Samuel David, Massimo Alessio |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | EMBO Molecular Medicine |
Subjects: | |
Online Access: | https://doi.org/10.15252/emmm.201708361 |
Similar Items
-
Aceruloplasminemia: Waiting for an Efficient Therapy
by: Alberto Piperno, et al.
Published: (2018-12-01) -
BRAIN IRON ACCUMULATION: DON’T FORGET ACERULOPLASMINEMIA
by: Paola Feraco
Published: (2020-07-01) -
Aceruloplasminemia Presenting with Cognitive Impairment
by: Yıldız Arslan, et al.
Published: (2017-09-01) -
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis
by: Marc Vila Cuenca, et al.
Published: (2020-03-01) -
The Role of Ceruloplasmin in Colitis
by: Bakhautdin, Bakytzhan
Published: (2010)